(opens original source in a new tab)STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the subject of a contentious regulatory review.
(opens original source in a new tab)© 2026 Industry Events Worldwide。保留所有权利。
一封简短的邮件。汇集塑造全球商业的展会、会议和峰会的头条新闻。没有废话,没有垃圾邮件,随时可取消订阅。